✦ LIBER ✦

Simultaneous detection of genetic and immunological markers in non-small cell lung cancer: prediction of metastatic potential of tumor

✍ Scribed by Irina Zborovskaya; Alexander Gasparian; Maria Kitaeva; Boris Polotzky; Nikolay Tupitzin; Zurab Machaladze; Sergey Gerasimov; Michail Shtutman; Marianna Jakubovskaya; Michail Davidov; Alexander Tatosyan

Publisher: Springer
Year: 1996
Tongue: English
Weight: 826 KB
Volume: 14
Category: Article
ISSN: 0262-0898
DOI: 10.1007/bf00115109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of serum ca 125 as a tumor ma

Evaluation of serum ca 125 as a tumor marker in non-small cell lung cancer

✍ Dr. M. Diez; F. J. Cerdàn; M. D. Ortega; A. Torres; A. Picardo; J. L. Balibrea 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB 👁 2 views

Isolation of a novel human lung-specific

Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer

✍ Kyoko Iwao; Takashi Watanabe; Yoshiyuki Fujiwara; Koji Takami; Ken Kodama; Masah 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 104 KB 👁 2 views

Tumor p16M is a possible marker of advan

Tumor p16M is a possible marker of advanced stage in non–small cell lung cancer

✍ Calvin S.H. Ng; Jun Zhang; Song Wan; Tak Wai Lee; Ahmed A. Arifi; Tony Mok; Denn 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

5-fluorouracil, etoposide, and cisplatin

5-fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer

✍ Lawrence Flaherty; Antoinette Wozniak; Bruce Redman; Michael Kraut; Silvana Mart 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 2 views

Phase II trial of gallium nitrate, amona

Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer

✍ Alex Y. Chang; Z. Nora Tu; Julia L. Smith; Philip Bonomi; Thomas J. Smith; Peter 📂 Article 📅 1995 🏛 Springer US 🌐 English ⚖ 330 KB

p16INK4A and CDH13 hypermethylation in t

p16INK4A and CDH13 hypermethylation in tumor and serum of non-small cell lung cancer patients

✍ Paola Ulivi; Wainer Zoli; Daniele Calistri; Francesco Fabbri; Anna Tesei; Marco 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB

## Abstract Aberrant promoter hypermethylation of several known or putative tumor suppressor genes occurs frequently during the etiopathogenesis of lung cancer and is a promising tool for cancer detection. In the present study, promoter hypermethylation of __p16^INK4A^__ and __CDH13__ genes was inv